Espervita Therapeutics is focused on the discovery of metabolic reprogramming therapies for the treatment of cancers in areas with a significant unmet medical need, with promising preclinical evidence for the treatment of liver cancer. The company is led by a team with deep expertise in metabolic reprogramming and broad experience in drug discovery and development. Website